HK Stock MarketDetailed Quotes

02197 CLOVER BIO-B

Watchlist

0.250
+0.001+0.40%

Market Closed Dec 24 12:08 CST

324.26MMarket Cap-0.33P/E (TTM)

CLOVER BIO-B Key Stats

Cash Flow

All

YOY

Hide blank lines

(Q6)Jun 30, 2024

(FY)Dec 31, 2023

(Q6)Jun 30, 2023

(FY)Dec 31, 2022

(Q6)Jun 30, 2022

(FY)Dec 31, 2021

(FY)Dec 31, 2020

(FY)Dec 31, 2019

Assets

Current assets

Inventory

-40.40%696.73M

-70.77%696.98M

-23.91%1.17B

210.18%2.38B

--1.54B

1,410.76%768.69M

12,846.82%50.88M

--393K

Accounts receivable

-99.31%4K

--24.11M

--581K

----

Advance deposits and other receivables

-25.37%73.59M

-49.09%68.8M

-90.83%98.6M

-90.63%135.15M

--1.08B

654.66%1.44B

3,532.48%191.03M

--5.26M

Cash and equivalents

-63.72%458.77M

-54.22%735.86M

-43.94%1.26B

-41.92%1.61B

--2.26B

436.12%2.77B

247.15%516.18M

--148.69M

Fixed time deposit-current assets

21.21%23.82M

-15.67%16.23M

-27.41%19.65M

-71.65%19.24M

--27.08M

-76.62%67.89M

2,803.28%290.33M

--10M

Secured deposit

45.40%347.17M

49.39%343.38M

--238.76M

--229.86M

----

Financial assets at fair value-current assets

-1.37%14.25M

1.69%14.17M

--14.45M

-54.93%13.93M

----

--30.91M

----

Total current assets

-42.46%1.61B

-56.73%1.9B

-42.68%2.81B

-13.52%4.39B

--4.89B

384.20%5.08B

537.94%1.05B

--164.35M

Non-current assets

Property, plant and equipment

-22.82%135.03M

-19.41%149.72M

4.02%174.95M

19.33%185.79M

--168.18M

136.26%155.69M

1,220.32%65.9M

--4.99M

Intangible assets

1.53%36.75M

13.89%39.86M

43.82%36.19M

153.10%35M

--25.16M

4,892.06%13.83M

-5.78%277K

--294K

Other illiquid assets

----

-61.90%18.26M

-14.88%28.04M

--47.92M

-36.47%32.93M

1,149.73%51.84M

--4.15M

Total non-current assets

-33.11%182.93M

-33.75%201.92M

-14.10%273.49M

13.23%304.78M

--318.38M

93.50%269.17M

536.04%139.1M

--21.87M

Total assets

-41.63%1.8B

-55.24%2.1B

-40.94%3.08B

-12.18%4.69B

--5.21B

350.15%5.35B

537.72%1.19B

--186.22M

Liabilities

Current liabilities

Accounts payable

-19.94%181.23M

-71.08%247.83M

-76.68%226.38M

45.60%856.96M

--970.73M

1,640.27%588.56M

372.02%33.82M

--7.17M

Other payables and accrued expenses

-23.51%77.92M

25.59%124.73M

-17.71%101.86M

-13.28%99.31M

--123.78M

299.66%114.52M

54.79%28.66M

--18.51M

Bank loans and overdrafts

-48.06%212.95M

4.76%308.06M

--409.95M

--294.06M

----

Financial lease liabilities-current liabilities

-49.42%12.06M

-21.36%18.54M

-8.62%23.84M

9.73%23.57M

--26.09M

404.34%21.48M

135.30%4.26M

--1.81M

Total current liabilities

-12.42%2.07B

-19.52%2.28B

-9.28%2.37B

31.71%2.83B

--2.61B

3,118.91%2.15B

142.78%66.73M

--27.49M

Net current assets

-204.71%-458.91M

-124.19%-377.48M

-80.82%438.25M

-46.70%1.56B

--2.29B

198.30%2.93B

617.30%981.69M

--136.86M

Total assets less current liabilities

-138.78%-275.98M

-109.41%-175.57M

-72.66%711.73M

-41.66%1.87B

--2.6B

185.29%3.2B

606.11%1.12B

--158.73M

Non-current liabilities

Long-term accounts payable

-1.37%508.19M

--505.05M

--515.25M

----

Financial lease liabilities-non-current liabilities

-72.48%6.1M

-78.62%7.85M

-59.07%22.15M

-20.89%36.74M

--54.13M

157.19%46.44M

69.63%18.06M

--10.65M

Deferred income-non-current liabilities

-70.84%42.51M

-98.22%44.36M

-93.86%145.78M

29.24%2.5B

--2.37B

101.63%1.93B

5,480.50%958.17M

--17.17M

Convertible notes and bonds

----

467.24%1.13B

--198.74M

Total non-current liabilities

-18.50%556.8M

-78.01%557.26M

-71.85%683.18M

28.06%2.53B

--2.43B

-5.95%1.98B

828.50%2.1B

--226.55M

Total liabilities

-13.78%2.63B

-47.15%2.83B

-39.43%3.05B

29.96%5.36B

--5.04B

90.14%4.13B

754.31%2.17B

--254.04M

Total assets less total liabilities

-3,016.59%-832.78M

-9.68%-732.83M

-83.83%28.55M

-154.80%-668.14M

--176.59M

224.06%1.22B

-1,349.00%-982.74M

---67.82M

Total equity and non-current liabilities

-138.78%-275.98M

-109.41%-175.57M

-72.66%711.73M

-41.66%1.87B

--2.6B

185.29%3.2B

606.11%1.12B

--158.73M

Equity

Share capital

0.24%838K

0.36%838K

12.37%836K

12.53%835K

--744K

--742K

----

Reserve

-3,104.02%-833.59M

-9.67%-733.64M

-84.22%27.75M

-154.90%-668.94M

--175.88M

223.99%1.22B

-1,349.00%-982.74M

---67.82M

Shareholders' Equity

-3,016.59%-832.78M

-9.68%-732.83M

-83.83%28.55M

-154.80%-668.14M

--176.59M

224.06%1.22B

-1,349.00%-982.74M

---67.82M

Total equity

-3,016.59%-832.78M

-9.68%-732.83M

-83.83%28.55M

-154.80%-668.14M

--176.59M

224.06%1.22B

-1,349.00%-982.74M

---67.82M

Total equity and total liabilities

-41.63%1.8B

-55.24%2.1B

-40.94%3.08B

-12.18%4.69B

--5.21B

350.15%5.35B

537.72%1.19B

--186.22M

Currency Unit

CNY

Accounting Standards

IAS

Audit Opinions

Unqualified Opinion

Auditor

Ernst & Young

	(Q6)Jun 30, 2024	(FY)Dec 31, 2023	(Q6)Jun 30, 2023	(FY)Dec 31, 2022	(Q6)Jun 30, 2022	(FY)Dec 31, 2021	(FY)Dec 31, 2020	(FY)Dec 31, 2019
Assets
Current assets
Inventory	-40.40%696.73M	-70.77%696.98M	-23.91%1.17B	210.18%2.38B	--1.54B	1,410.76%768.69M	12,846.82%50.88M	--393K
Accounts receivable	-99.31%4K	--24.11M	--581K	----	----	----	----	----
Advance deposits and other receivables	-25.37%73.59M	-49.09%68.8M	-90.83%98.6M	-90.63%135.15M	--1.08B	654.66%1.44B	3,532.48%191.03M	--5.26M
Cash and equivalents	-63.72%458.77M	-54.22%735.86M	-43.94%1.26B	-41.92%1.61B	--2.26B	436.12%2.77B	247.15%516.18M	--148.69M
Fixed time deposit-current assets	21.21%23.82M	-15.67%16.23M	-27.41%19.65M	-71.65%19.24M	--27.08M	-76.62%67.89M	2,803.28%290.33M	--10M
Secured deposit	45.40%347.17M	49.39%343.38M	--238.76M	--229.86M	----	----	----	----
Financial assets at fair value-current assets	-1.37%14.25M	1.69%14.17M	--14.45M	-54.93%13.93M	----	--30.91M	----	----
Total current assets	-42.46%1.61B	-56.73%1.9B	-42.68%2.81B	-13.52%4.39B	--4.89B	384.20%5.08B	537.94%1.05B	--164.35M
Non-current assets
Property, plant and equipment	-22.82%135.03M	-19.41%149.72M	4.02%174.95M	19.33%185.79M	--168.18M	136.26%155.69M	1,220.32%65.9M	--4.99M
Intangible assets	1.53%36.75M	13.89%39.86M	43.82%36.19M	153.10%35M	--25.16M	4,892.06%13.83M	-5.78%277K	--294K
Other illiquid assets	----	----	-61.90%18.26M	-14.88%28.04M	--47.92M	-36.47%32.93M	1,149.73%51.84M	--4.15M
Total non-current assets	-33.11%182.93M	-33.75%201.92M	-14.10%273.49M	13.23%304.78M	--318.38M	93.50%269.17M	536.04%139.1M	--21.87M
Total assets	-41.63%1.8B	-55.24%2.1B	-40.94%3.08B	-12.18%4.69B	--5.21B	350.15%5.35B	537.72%1.19B	--186.22M
Liabilities
Current liabilities
Accounts payable	-19.94%181.23M	-71.08%247.83M	-76.68%226.38M	45.60%856.96M	--970.73M	1,640.27%588.56M	372.02%33.82M	--7.17M
Other payables and accrued expenses	-23.51%77.92M	25.59%124.73M	-17.71%101.86M	-13.28%99.31M	--123.78M	299.66%114.52M	54.79%28.66M	--18.51M
Bank loans and overdrafts	-48.06%212.95M	4.76%308.06M	--409.95M	--294.06M	----	----	----	----
Financial lease liabilities-current liabilities	-49.42%12.06M	-21.36%18.54M	-8.62%23.84M	9.73%23.57M	--26.09M	404.34%21.48M	135.30%4.26M	--1.81M
Total current liabilities	-12.42%2.07B	-19.52%2.28B	-9.28%2.37B	31.71%2.83B	--2.61B	3,118.91%2.15B	142.78%66.73M	--27.49M
Net current assets	-204.71%-458.91M	-124.19%-377.48M	-80.82%438.25M	-46.70%1.56B	--2.29B	198.30%2.93B	617.30%981.69M	--136.86M
Total assets less current liabilities	-138.78%-275.98M	-109.41%-175.57M	-72.66%711.73M	-41.66%1.87B	--2.6B	185.29%3.2B	606.11%1.12B	--158.73M
Non-current liabilities
Long-term accounts payable	-1.37%508.19M	--505.05M	--515.25M	----	----	----	----	----
Financial lease liabilities-non-current liabilities	-72.48%6.1M	-78.62%7.85M	-59.07%22.15M	-20.89%36.74M	--54.13M	157.19%46.44M	69.63%18.06M	--10.65M
Deferred income-non-current liabilities	-70.84%42.51M	-98.22%44.36M	-93.86%145.78M	29.24%2.5B	--2.37B	101.63%1.93B	5,480.50%958.17M	--17.17M
Convertible notes and bonds	----	----	----	----	----	----	467.24%1.13B	--198.74M
Total non-current liabilities	-18.50%556.8M	-78.01%557.26M	-71.85%683.18M	28.06%2.53B	--2.43B	-5.95%1.98B	828.50%2.1B	--226.55M
Total liabilities	-13.78%2.63B	-47.15%2.83B	-39.43%3.05B	29.96%5.36B	--5.04B	90.14%4.13B	754.31%2.17B	--254.04M
Total assets less total liabilities	-3,016.59%-832.78M	-9.68%-732.83M	-83.83%28.55M	-154.80%-668.14M	--176.59M	224.06%1.22B	-1,349.00%-982.74M	---67.82M
Total equity and non-current liabilities	-138.78%-275.98M	-109.41%-175.57M	-72.66%711.73M	-41.66%1.87B	--2.6B	185.29%3.2B	606.11%1.12B	--158.73M
Equity
Share capital	0.24%838K	0.36%838K	12.37%836K	12.53%835K	--744K	--742K	----	----
Reserve	-3,104.02%-833.59M	-9.67%-733.64M	-84.22%27.75M	-154.90%-668.94M	--175.88M	223.99%1.22B	-1,349.00%-982.74M	---67.82M
Shareholders' Equity	-3,016.59%-832.78M	-9.68%-732.83M	-83.83%28.55M	-154.80%-668.14M	--176.59M	224.06%1.22B	-1,349.00%-982.74M	---67.82M
Total equity	-3,016.59%-832.78M	-9.68%-732.83M	-83.83%28.55M	-154.80%-668.14M	--176.59M	224.06%1.22B	-1,349.00%-982.74M	---67.82M
Total equity and total liabilities	-41.63%1.8B	-55.24%2.1B	-40.94%3.08B	-12.18%4.69B	--5.21B	350.15%5.35B	537.72%1.19B	--186.22M
Currency Unit	CNY	CNY	CNY	CNY	CNY	CNY	CNY	CNY
Accounting Standards	IAS	IAS	IAS	IAS	IAS	IAS	IAS	IAS
Audit Opinions	--	Unqualified Opinion	--	Unqualified Opinion	--	Unqualified Opinion	Unqualified Opinion	Unqualified Opinion
Auditor	--	Ernst & Young	--	Ernst & Young	--	Ernst & Young	Ernst & Young	Ernst & Young

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Heat List

Overall

No Data

Investment Theme

Pharmaceutical Companies

Intraday+0.88%

02197 CLOVER BIO-B

CLOVER BIO-B Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow